STERIS plc announced that Chairman of the Board John P. (Jack) Wareham will not stand for re-election to the Board of Directors when his term expires on July 31, 2018, at the company's 2018 Annual General Meeting of Shareholders. Mr. Wareham has been a member of the Board since 2000 and has served as Chairman of the Board since 2005. The Board of Directors expects to appoint current independent director Dr. Mohsen M. Sohi to the role of Chairman of the Board, if he is re-elected as a Board member by shareholders at the 2018 AGM. Effective May 4, 2018, the company also appointed Dr. Nirav Shah to the Board. Previously Dr. Shah served as Commissioner of Health of the State of New York from January 2011 to May 2014, and as Senior Vice President and Chief Operating Officer for Clinical Operations for Kaiser Permanente Southern California from May 2014 to October 2017. Since October 2017, Dr. Shah has served as a healthcare industry consultant.
STERIS plc is one of the world's leading providers of infection control solutions and procedural services. Net sales break down by activity as follows:
- sales of infection control solutions (62.9%): including cleaning and sterilization chemicals, accessories for gastrointestinal procedures, washers, sterilizers and operating room equipment (including surgical tables, lighting and connectivity solutions). In addition, the group offers specialized healthcare services (sterilization services, instrument and endoscope repair and maintenance and customized process improvement consulting in acute care hospitals);
- development of applied sterilization solutions (22.1%): contract development of sterilization modalities and laboratory testing services for more than 50 sterilization and laboratory facilities worldwide;
- manufacturing of consumables and maintenance equipment (15%): dedicated to pharmaceutical manufacturers.
Net sales by source of income are divided into sales of services (53.5%), sales of consumables (23.4%) and sales of equipment (23.1%).
Net sales are distributed geographically as follows Ireland (2.3%), the United States (71.7%) and other (26%).
STERIS PLC 
